Markers of Glycaemic Control: relationship between real-time glucose and glycated haemoglobin (HbA1c) and glycated albumin (GA) in diabetics with end-stage renal disease and diabetics with normal renal function.

niversity of Otago0 个研究点目标入组 52 人开始时间: 2010年2月12日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•All participants:
•At least 18 years of age, control patients estimated glomerular filtration rate (eGFR) >60ml/min, stable diabetes mellitus (type 1 and type 2) (no change in medications over the past 2 months)
•Participants with end-stage renal disease:
•Stable and on dialysis for at least 2 months or predialysis with eGFR <30ml/min, on erythropoietin or iron supplement therapy, haemoglobin within the recommended target range (Hb: 110-130 g/l)

•Inability to give informed consent, haemoglobinopathies, hypoalbuminaemia of any cause, anaemia of any cause (except secondary to renal disease), blood transfusion of whole blood or red blood cells within 30 days prior to study entry, chronic liver disease, steroid therapy, current acute illness or malignancy, pregnancy.

发起方